These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 27446541)

  • 1. Pharmacokinetic analyses of carboplatin in a patient with cancer of the fallopian tubes undergoing hemodialysis: A case report.
    Wada T; Fukuda T; Kawanishi M; Tasaka R; Imai K; Yamauchi M; Kasai M; Hashiguchi Y; Ichimura T; Yasui T; Sumi T
    Biomed Rep; 2016 Aug; 5(2):199-202. PubMed ID: 27446541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of combination chemotherapy with paclitaxel and carboplatin in a patient with advanced epithelial ovarian cancer undergoing hemodialysis.
    Kodama J; Sasaki A; Masahiro S; Seki N; Kusumoto T; Nakamura K; Hongo A; Hiramatsu Y
    Oncol Lett; 2010 May; 1(3):511-513. PubMed ID: 22966334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of paclitaxel and carboplatin in a hemodialysis patient with advanced ovarian cancer.
    Yoshida H; Sumi T; Abe K; Ishiko O
    Eur J Gynaecol Oncol; 2009; 30(5):583-5. PubMed ID: 19899423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel and carboplatin combination chemotherapy in a hemodialysis patient with advanced ovarian cancer.
    Watanabe M; Aoki Y; Tomita M; Sato T; Takaki Y; Kato N; Kikuchi M; Kase H; Tanaka K
    Gynecol Oncol; 2002 Feb; 84(2):335-8. PubMed ID: 11812097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Safe and effective administration of carboplatin-based chemotherapy in a patient undergoing hemodialysis with cancer of unknown primary by monitoring observed AUC of carboplatin-a case report].
    Kondo M; Kuroda J; Ikai Y; Hayashi R; Uegaki S; Yoshida T; Yoshida A; Komatsu H; Kimura K
    Gan To Kagaku Ryoho; 2012 Nov; 39(11):1749-52. PubMed ID: 23152033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic analysis of paclitaxel and carboplatin in a patient with advanced ovarian cancer during hemodialysis--case report.
    Yokoyama Y; Futagami M; Higuchi T; Mizunuma H
    Eur J Gynaecol Oncol; 2006; 27(4):437-9. PubMed ID: 17009648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of Carboplatin in a One-Year-Old Anuric Boy Undergoing Hemodialysis and a Review of the Literature.
    Kamei K; Sako M; Ishikawa T; Sato M; Ogura M; Uno T; Kiyotani C; Mori T; Tanaka H; Ito S; Nakamura H
    Ther Apher Dial; 2015 Oct; 19(5):491-6. PubMed ID: 25916242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of carboplatin in a hemodialysis patient with small-cell lung cancer.
    Hiraike M; Hiraki Y; Misumi N; Hanada K; Tsuji Y; Kamimura H; Karube Y; Kashiwabara K
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):845-8. PubMed ID: 22194156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic analysis of carboplatin in patients with cancer who are undergoing hemodialysis.
    Oguri T; Shimokata T; Inada M; Ito I; Ando Y; Sasaki Y; Hasegawa Y
    Cancer Chemother Pharmacol; 2010 Sep; 66(4):813-7. PubMed ID: 20563583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of tolerability and quality of life for carboplatin-based chemotherapy in an elderly urothelial carcinoma patient undergoing hemodialysis: a case report.
    Kondo M; Naiki T; Hotta Y; Yamamoto Y; Sugiyama Y; Yasui T; Kimura K
    J Pharm Health Care Sci; 2018; 4():29. PubMed ID: 30519478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extension of the Calvert formula to patients with severe renal insufficiency.
    Oguri T; Shimokata T; Ito I; Yasuda Y; Sassa N; Nishiyama M; Hamada A; Hasegawa Y; Ando Y
    Cancer Chemother Pharmacol; 2015 Jul; 76(1):53-9. PubMed ID: 25957958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of paclitaxel and carboplatin in a hemodialysis patient with metastatic urothelial carcinoma--a case report].
    Furuya Y; Takihana Y; Araki I; Tanabe N; Takeda M
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):1017-20. PubMed ID: 12894722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of carboplatin in a patient suffering from advanced ovarian carcinoma with hemodialysis-dependent renal insufficiency.
    Chatelut E; Rostaing L; Gualano V; Vissac T; De Forni M; Ton-That H; Suc JM; Houin G; Canal P
    Nephron; 1994; 66(2):157-61. PubMed ID: 8139735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial.
    Oza AM; Cibula D; Benzaquen AO; Poole C; Mathijssen RH; Sonke GS; Colombo N; Špaček J; Vuylsteke P; Hirte H; Mahner S; Plante M; Schmalfeldt B; Mackay H; Rowbottom J; Lowe ES; Dougherty B; Barrett JC; Friedlander M
    Lancet Oncol; 2015 Jan; 16(1):87-97. PubMed ID: 25481791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer.
    Wang Y; Herrstedt J; Havsteen H; DePoint Christensen R; Mirza MR; Lund B; Maenpaa J; Kristensen G
    BMC Cancer; 2014 Dec; 14():937. PubMed ID: 25494701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I trial, including pharmacokinetic and pharmacodynamic correlations, of combination paclitaxel and carboplatin in patients with metastatic non-small-cell lung cancer.
    Belani CP; Kearns CM; Zuhowski EG; Erkmen K; Hiponia D; Zacharski D; Engstrom C; Ramanathan RK; Capozzoli MJ; Aisner J; Egorin MJ
    J Clin Oncol; 1999 Feb; 17(2):676-84. PubMed ID: 10080614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I study evaluating the safety and pharmacokinetics of weekly paclitaxel and carboplatin in relapsed ovarian cancer.
    Leiser AL; Maluf FC; Chi DS; Sabbatini P; Hensley ML; Schwartz L; Venkatraman E; Spriggs D; Aghajanian C
    Int J Gynecol Cancer; 2007; 17(2):379-86. PubMed ID: 17362316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin.
    Kristensen GB; Vergote I; Stuart G; Del Campo JM; Kaern J; Lopez AB; Eisenhauer E; Aavall-Lundquist E; Ridderheim M; Havsteen H; Mirza MR; Scheistroen M; Vrdoljak E
    Int J Gynecol Cancer; 2003; 13 Suppl 2():172-7. PubMed ID: 14656276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance of twenty-four hour paclitaxel and carboplatin as first-line therapy in ovarian, peritoneal and fallopian tube carcinoma.
    Rose PG; Fusco N; Fluellen L; Rodriguez M
    Int J Gynecol Cancer; 1999 Nov; 9(6):448-451. PubMed ID: 11240809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining platinum, paclitaxel and anthracycline in patients with advanced gynaecological malignancy.
    Gregory RK; Hill ME; Moore J; A'Hern RP; Johnston SR; Blake P; Shephard J; Barton D; Gore ME
    Eur J Cancer; 2000 Mar; 36(4):503-7. PubMed ID: 10717527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.